These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1494868)

  • 1. [Hyperinsulinism and the coronary syndrome].
    Hrnciar J
    Vnitr Lek; 1992 Nov; 38(11):1056-65. PubMed ID: 1494868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical manifestations of the insulin resistance syndrome. The hormonal-metabolic syndrome X, the 5H syndrome and their etiopathogenesis].
    Hrnciar J
    Vnitr Lek; 1995 Feb; 41(2):92-8. PubMed ID: 7725646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relation between levels of leptin, insulin and cortisol in persons with the 5H (X) syndrome].
    Hrnciar J; Okapcová J; Lepej J; Gábor D
    Vnitr Lek; 1998 Feb; 44(2):68-75. PubMed ID: 9820079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Amylin as an additional possible pathogenic factor in NIDDM and the insulin resistance syndrome].
    Hrnciar J
    Vnitr Lek; 1996 Aug; 42(8):557-60. PubMed ID: 8967027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The dilemma of syndrome X].
    Hrnciar J
    Vnitr Lek; 1992 Nov; 38(11):1041-4. PubMed ID: 1494865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical manifestations of insulin resistance. The hormonal-metabolic syndrome X (5H), its prevalence and impact on cardiovascular morbidity and mortality. I].
    Hrnciar J; Hrnciarová M; Jakubíková K; Okapcová J
    Vnitr Lek; 1992 May; 38(5):426-37. PubMed ID: 1509712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hyperinsulinism as a major etiopathogenic link with arterial hypertension, hyperlipoproteinemia and hirsutism. II].
    Hrnciar J; Hrnciarová M; Jakubíková K; Okapcová J
    Vnitr Lek; 1992 May; 38(5):438-47. PubMed ID: 1509713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Insulin resistance and arterial hypertension. Hyperinsulinism as a basic etiopathogenic factor in essential arterial hypertension and associated phenomena].
    Hrnciar J; Hrnciarová M; Jakubíková K; Korónyi S
    Vnitr Lek; 1992 Sep; 38(9):868-78. PubMed ID: 1481385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [How should we implement the basic principles of treatment of type 2 diabetes mellitus from the aspect of the hormono-metabolic syndrome X (5H)?].
    Hrnciar J; Jakubíková K; Okapcová J
    Vnitr Lek; 1992 Aug; 38(8):729-37. PubMed ID: 1455753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Methods of measuring hyperinsulinism and insulin resistance].
    Hrnciar J
    Vnitr Lek; 1993 May; 39(5):481-6. PubMed ID: 8351881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Occurrence of diabetes, hyperinsulinism and other risk factors for atherosclerosis in patients with pernicious anemia].
    Kessler P; Veberová J; Bradácková I
    Vnitr Lek; 1998 Apr; 44(4):222-6. PubMed ID: 9820107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of abdominal obesity in pathogenesis of insulin resistance syndrome].
    Almazov VA; Blagosklonnaia IaV; Shliakhto EV; Krasil'nikova EI
    Ter Arkh; 1999; 71(10):18-22. PubMed ID: 10612167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The value of certain parameters in the diagnosis and detection of metabolic X syndrome].
    Suba I; Halmos T; Kautzky L
    Orv Hetil; 1997 Sep; 138(38):2407-11. PubMed ID: 9380379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The metabolic syndrome, its heredity, methods of detection and clinical significance].
    Válek J; Vlasáková Z
    Vnitr Lek; 1997 Sep; 43(9):566-73. PubMed ID: 9750464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type II diabetes and syndrome X. Pathogenesis and glycemic management.
    Karam JH
    Endocrinol Metab Clin North Am; 1992 Jun; 21(2):329-50. PubMed ID: 1612069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperinsulinemia in patients with coronary heart disease in absence of overt risk factors.
    Ariza CR; Frati AC; Gómez G; Almazán A
    Arch Med Res; 1997; 28(1):115-9. PubMed ID: 9078598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperinsulinism in patients with coronary artery disease.
    Job FP; Wolfertz J; Meyer R; Hübinger A; Gries FA; Kuhn H
    Coron Artery Dis; 1994 Jun; 5(6):487-92. PubMed ID: 7952407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Insulin resistance and cardiovascular complications].
    Janka HU
    Wien Klin Wochenschr; 1994; 106(24):758-62. PubMed ID: 7846894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clustering of impaired glucose tolerance, hyperinsulinemia and dyslipidemia in young north Indian patients with coronary heart disease: a preliminary case-control study.
    Misra A; Reddy RB; Reddy KS; Mohan A; Bajaj JS
    Indian Heart J; 1999; 51(3):275-80. PubMed ID: 10624065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.